| 产品名称： | BCL2 Jurkat |
|---|---|
| 商品货号： | TS160499 |
| Organism： | Homo sapiens, human |
| Tissue： | peripheral blood |
| Cell Type： | T Cell/ T Lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoid-like |
| Culture Properties： | suspension |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | acute T cell leukemia |
| Age： | 14 years |
| Gender： | male |
| Applications： | This cell line over-expresses BCL-2, and is useful to study cell apoptosis, BCL-2 function and its pathway. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Images： |  |
| Derivation： | The BCL2 Jurkat cell line was derived by transfecting human Jurkat T cells with the pSFFV-neo mammalian expression vector containing the human BCL-2 ORF insert and a neomycin-resistant gene (Addgene # 3349).xa0 Stable neomycin (Neo)-resistant single-cell-originated clones were isolated and expanded by selection in medium containing 1 mg/mL G418 for 14 days (1). |
| Cellular Products： | Neomycin resistance gene, expressed BCL2 over-expressed, verified at ATCC |
| Tumorigenic： | Yes |
| Comments： | The BCL2 Jurkat cell line was derived by transfecting human Jurkat T cells with the pSFFV-neo mammalian expression vector containing the human BCL-2 ORF insert and a neomycin-resistant gene (Addgene # 3349).xa0xa0 Stable neomycin (Neo)-resistant single-cell-originated clones were isolated and expanded by selection in medium containing 1 mg/mL G418 for 14 days (1). xa0The BCL2 Jurkat cell line produces over-expression of human BCL-2. |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated RPMI-1640 Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: 10% FBS and 200 mcg/mL G418.
|
| Subculturing： | Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension in fresh medium. An inoculum of 2 x 105 to 3 x 105 cells/mL is recommended. Subculture when cell concentration is 2 x 106 cells/mL. Subcultivation ratio: A subcultivation ratio of 1:2 to 1:10 is recommended.Medium renewal: Add fresh medium every 2 to 3 days (depending on cell density) |
| Cryopreservation： | Freeze medium: 90% Fetal Bovine Serum and 10% DMSO Storage temperature: liquid nitrogen vapor phase |
| Culture Conditions： | Temperature: 37°C Atmosphere: air, 95%; carbon dioxide (CO2), 5% |
| STR Profile： | D5S818: 9 D13S317: 8, 12 D7S820: 8, 12 D16S539: 11 vWA: 18, 19 TH01: 6, 9.3 Amelogenin: X Y TPOX: 8, 10 CSF1PO: 11, 12 |
| Name of Depositor： | Stanley Korsmeyer |
| Year of Origin： | 2003 |
| References： | Yamamoto K, et al. BCL-2 is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway normally Activated at G2/M. Mol Cell Biol. Dec;19(12):8469-78. 1999. PubMed: 10567572 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | BCL2 Jurkat |
|---|---|
| 商品货号： | TS160499 |
| Organism： | Homo sapiens, human |
| Tissue： | peripheral blood |
| Cell Type： | T Cell/ T Lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoid-like |
| Culture Properties： | suspension |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | acute T cell leukemia |
| Age： | 14 years |
| Gender： | male |
| Applications： | This cell line over-expresses BCL-2, and is useful to study cell apoptosis, BCL-2 function and its pathway. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Images： | |
| Derivation： | The BCL2 Jurkat cell line was derived by transfecting human Jurkat T cells with the pSFFV-neo mammalian expression vector containing the human BCL-2 ORF insert and a neomycin-resistant gene (Addgene # 3349).xa0 Stable neomycin (Neo)-resistant single-cell-originated clones were isolated and expanded by selection in medium containing 1 mg/mL G418 for 14 days (1). |
| Cellular Products： | Neomycin resistance gene, expressed BCL2 over-expressed, verified at ATCC |
| Tumorigenic： | Yes |
| Comments： | The BCL2 Jurkat cell line was derived by transfecting human Jurkat T cells with the pSFFV-neo mammalian expression vector containing the human BCL-2 ORF insert and a neomycin-resistant gene (Addgene # 3349).xa0xa0 Stable neomycin (Neo)-resistant single-cell-originated clones were isolated and expanded by selection in medium containing 1 mg/mL G418 for 14 days (1). xa0The BCL2 Jurkat cell line produces over-expression of human BCL-2. |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated RPMI-1640 Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: 10% FBS and 200 mcg/mL G418.
|
| Subculturing： | Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension in fresh medium. An inoculum of 2 x 105 to 3 x 105 cells/mL is recommended. Subculture when cell concentration is 2 x 106 cells/mL. Subcultivation ratio: A subcultivation ratio of 1:2 to 1:10 is recommended.Medium renewal: Add fresh medium every 2 to 3 days (depending on cell density) |
| Cryopreservation： | Freeze medium: 90% Fetal Bovine Serum and 10% DMSO Storage temperature: liquid nitrogen vapor phase |
| Culture Conditions： | Temperature: 37°C Atmosphere: air, 95%; carbon dioxide (CO2), 5% |
| STR Profile： | D5S818: 9 D13S317: 8, 12 D7S820: 8, 12 D16S539: 11 vWA: 18, 19 TH01: 6, 9.3 Amelogenin: X Y TPOX: 8, 10 CSF1PO: 11, 12 |
| Name of Depositor： | Stanley Korsmeyer |
| Year of Origin： | 2003 |
| References： | Yamamoto K, et al. BCL-2 is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway normally Activated at G2/M. Mol Cell Biol. Dec;19(12):8469-78. 1999. PubMed: 10567572 |
